Q BioMed Inc. (QBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST
Q BioMed Revenue
Q BioMed had revenue of $209.29K in the twelve months ending February 28, 2023, down -22.67% year-over-year. In the fiscal year ending November 30, 2022, Q BioMed had annual revenue of $284.35K with 45.38% growth.
Revenue (ttm)
209.29K
Revenue Growth
-22.67%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
145.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2022 | 284.35K | 88.76K | 45.38% |
| Nov 30, 2021 | 195.60K | 165.60K | 551.99% |
| Nov 30, 2020 | 30.00K | - | - |
| Nov 30, 2019 | - | - | - |
| Nov 30, 2018 | - | - | - |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oriental Bioengineering | 121.58M |
| RVL Pharmaceuticals | 36.92M |
| Infinity Pharmaceuticals | 2.57M |
| Seelos Therapeutics | 2.01M |
| Marizyme | 183.42K |
| Nanobac Pharmaceuticals | 17.62K |
| NanoLogix | 1.27K |
| Navidea Biopharmaceuticals | 610.00 |